Vascular birthmarks: a care study of an infant with haemangioma

Jackie Stephen-Haynes1

  • 1Worcestershire Primary Care Trusts, Stourport Health Centre, Stourport-On-Severn, Worcestershire, UK.

British Journal of Nursing (Mark Allen Publishing)
|March 5, 2004
PubMed

Insights

This case study applies evidence-based practice to infant sacral haemangioma care, focusing on wound, pain, and infection management. Reflective practice enhances holistic care delivery and understanding of clinical practice.

Area of Science:

  • Pediatric Dermatology
  • Evidence-Based Nursing
  • Clinical Case Study

Background:

  • Sacral haemangiomas require specialized management in infants.
  • Integrating clinical governance and evidence-based practice is crucial in healthcare delivery.
  • Holistic patient assessment necessitates considering nursing theories and models.

Observation:

  • A case study detailing the management of an infant with a sacral haemangioma.
  • Focus on therapeutic modalities, local wound care, pain management, and infection control.
  • Application of current evidence to a primary care setting.

Findings:

  • Critical appraisal of evidence for haemangioma and wound management.
  • Relevance of recent pain management strategies during dressing changes highlighted.
  • Demonstrated application of evidence-based principles in a real-world clinical scenario.

Implications:

  • Reflective practice is integral to experiential learning and knowledge development in nursing.
  • Critical analysis and reflection enhance the quality of patient care.
  • Improved understanding of the interplay between theory and practice in clinical settings.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...